KOSPIHolding Companies000230

Ildong Holdings

₩5,220▼ 0.57%2026-11-18 close
Market Cap
₩60.2B
Turnover
₩48,775,715
Volume
9.4K
Shares out.
11.5M
PER
3.3×
PBR
0.4×
EPS
₩1,587
Dividend Yield
1.91%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩100 per share · Prices as of the 2026-11-18 close

01

Report overview

Ildong Holdings: Operating Recovery, Volatile Net Income

Ildong Holdings returned to operating profit in 2025 and grew operating income in Q1 and Q3 2026 year on year, but net income attributable to controlling shareholders has posted two straight loss quarters since Q2 2026, making earnings continuity the key test.

  1. 1

    Operating profit of KRW 14.9 billion in 2025 marked a swing from operating loss, and the debt ratio fell from 410.1% in 2022 to 132.3% in 2025.

  2. 2

    Revenue rose in Q2 and Q3 2026, two consecutive quarters of growth, and Q3 revenue of KRW 157.8 billion was up 9.3% year on year.

  3. 3

    Net loss attributable to controlling shareholders was KRW 16.4 million in Q2 2026 and KRW 2.36 billion in Q3 2026, while the last four quarters combined total KRW 18.3 billion of net income attributable to controlling shareholders.

  4. 4

    Consolidated R&D expense fell from KRW 108 billion in 2023 to KRW 35.5 billion in 2025, then rose 14.6% year on year to KRW 9.2 billion in Q1 2026.

  5. 5

    Parent-only revenue is a small share of consolidated sales, and in late March 2026 the company approved its fiscal 2025 financial statements and resolved a cash dividend.

02

Business structure

Ildong Holdings is the holding company of the Ildong group, which moved to a holding structure through a spin-off effective August 1, 2016. As of the Q1 2026 quarterly report, the group had 16 affiliates, of which 2 are listed, including Ildong Holdings, and 14 are unlisted.

Parent-only operations consist of one holding business, earning service fees from affiliates, brand royalties, headquarters rent and dividends from affiliates and investees.

In Q1 2026, parent-only revenue of KRW 8.41 billion was made up of service fees at 51.21%, dividends at 27.32%, rent at 11.61% and brand royalties at 9.86%. In the fiscal 2024 business report filed in March 2025, dividends were only 0.93% of parent revenue, so this mix shifts sharply between years.

Fiscal 2025 parent-only revenue was KRW 18.8 billion with operating profit of KRW 1.59 billion, as disclosed in March 2026. The principal consolidated subsidiary is IL Dong Pharmaceutical, while other affiliates include a health-functional food unit and a water-ionizer business.

The holding company has no production facilities, so affiliate operations generate most consolidated results. Parent-only revenue in Q1 2026 was a small fraction of consolidated revenue of KRW 148.9 billion, so the two sets of figures differ sharply.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩144.3B₩6.1B4.2%
2025Q4₩153.8B₩7.2B4.7%
2026Q1₩148.9B₩8.9B6.0%
2026Q2₩154B₩1.9B1.3%
2026Q3₩157.8B₩7.2B4.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩675.5B-₩98.4B-₩102.4B−14.6%−866.4%410.1%
2023₩638.4B-₩79.6B-₩59.6B−12.5%−152.9%416.2%
2024₩657.6B-₩2.4B₩63B−0.4%47.1%236.5%
2025₩590.9B₩14.9B₩10.9B2.5%6.5%132.3%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-18

04

Earnings analysis

Annual revenue moved from KRW 675.5 billion in 2022 to KRW 638.4 billion in 2023 (down 5.5% year on year), KRW 657.6 billion in 2024 (up 3.0%) and KRW 590.9 billion in 2025 (down 10.1%), with 2022 the largest year and 2025 the smallest across 2022 to 2025.

Operating losses of KRW 98.4 billion in 2022 and KRW 79.6 billion in 2023 narrowed to an operating loss of KRW 2.41 billion in 2024, and then became operating profit of KRW 14.9 billion in 2025, a swing from loss. Operating margin improved from -14.6% in 2022 and -12.5% in 2023 to -0.4% in 2024 and 2.5% in 2025.

Net loss attributable to controlling shareholders of KRW 102.4 billion in 2022 and KRW 59.6 billion in 2023 turned into net income of KRW 63 billion in 2024, then fell 82.7% to KRW 10.9 billion in 2025.

Net income including non-controlling interests, which is a different measure, was KRW 21.6 billion in 2025 and should be read separately. Operating cash flow moved from negative KRW 74.6 billion in 2022 and negative KRW 57.8 billion in 2023 to positive KRW 17.3 billion in 2024 and KRW 26.9 billion in 2025.

Consolidated R&D expense fell from KRW 108 billion in 2023 to KRW 55.7 billion in 2024 and KRW 35.5 billion in 2025 according to FnGuide data, a period that overlaps with the operating turnaround.

The debt ratio fell from 410.1% in 2022 and 416.2% in 2023 to 236.5% in 2024 and 132.3% in 2025, and at end-2025 total liabilities were KRW 457.3 billion against total equity of KRW 345.6 billion, of which KRW 168.8 billion belonged to controlling shareholders.

Quarterly revenue went from KRW 144.3 billion in Q3 2025 to KRW 153.8 billion in Q4 2025 (up 6.6% QoQ), KRW 148.9 billion in Q1 2026 (down 3.2%), KRW 154 billion in Q2 2026 (up 3.4%) and KRW 157.8 billion in Q3 2026 (up 2.5% QoQ and 9.3% YoY).

Operating profit was KRW 6.13 billion in Q3 2025, KRW 7.24 billion in Q4 2025 (up 18.0% QoQ), KRW 8.89 billion in Q1 2026 (up 22.8%), KRW 1.93 billion in Q2 2026 (down 78.3%) and KRW 7.24 billion in Q3 2026 (up 275.1% QoQ and 18.1% YoY).

Net income attributable to controlling shareholders peaked at KRW 19.3 billion in Q4 2025, then moved to a net loss of KRW 16.4 million in Q2 2026 and KRW 2.36 billion in Q3 2026, so quarterly swings are large.

Whether one-off items drove the Q4 2025 gain and the 2026 losses should be checked in the notes to the quarterly reports.

05

Industry analysis

Ildong Holdings is a holding company with no production facilities, and its income depends on the profits of affiliates in pharmaceuticals, health-functional foods and consumer health, received through equity stakes and fees.

Since the 2016 spin-off, its business has rested on investment income, brand fees, management consulting fees and rent. Demand and cycle conditions in the end markets reach the holding company's results indirectly through affiliates, so reading its earnings depends on affiliate profit trends.

Consolidated R&D expense fell from KRW 108 billion in 2023 to KRW 55.7 billion in 2024 and KRW 35.5 billion in 2025 according to FnGuide, while selling, general and administrative expenses dropped from KRW 291.8 billion to KRW 210.2 billion over the same period.

The cost reduction appears to have helped the operating turnaround, but the filings alone cannot separate how much came from gross profit recovery versus lower costs. Whether lower R&D spending reflects a change in pipeline direction is a question for the pharmaceutical affiliate's business reports.

A simple comparison with other listed holding companies can mislead because affiliate mix and ownership structures differ. The value of a holding company depends on what its affiliates contribute, so the profit recovery of the pharmaceutical affiliate is the central variable.

Because parent-only revenue is a small part of consolidated sales, earnings attribution depends on ownership structure, as the gap between 2025 net income of KRW 21.6 billion and net income attributable to controlling shareholders of KRW 10.9 billion shows.

06

Outlook

Operating profit was KRW 8.89 billion in Q1 2026 and KRW 7.24 billion in Q3 2026, both up year on year, while Q2 2026 operating profit of KRW 1.93 billion shows how wide the quarterly swings can be.

Revenue rose in Q2 and Q3 2026, two consecutive quarters of growth, and Q3 revenue of KRW 157.8 billion was up 9.3% year on year. Net loss attributable to controlling shareholders of KRW 16.4 million in Q2 2026 and KRW 2.36 billion in Q3 2026 shows a weak conversion of operating profit into shareholder earnings.

A material matters report on put-back option and related contract decisions, with a corrected filing dated September 30, 2026, is on DART, and its financial effect should be checked in the upcoming periodic reports.

The company approved fiscal 2025 financial statements and resolved a cash dividend in March 2026, so the continuity of shareholder returns will be tested at the next regular general meeting.

The next periodic report is the 2026 annual business report, and its annual operating margin and net income attributable to controlling shareholders are the next checkpoints.

Fourth-quarter 2026 results will be part of the 2026 annual totals, so whether quarterly results were affected by one-off items should be checked as well. The pace of affiliate profit recovery and the level of R&D spending are the variables that will shape the outlook beyond 2027.

07

Valuation

PER
3.3×
PBR
0.4×
ROE
12.1%
EPS
₩1,587
BPS
₩14,775
Dividend per share
₩100

As of November 18, 2026, the share price sits at a discount to book value, with the price-to-book ratio well below 1x. Market capitalization is below the controlling shareholders' stake of KRW 168.8 billion at end-2025.

On an earnings basis, net income attributable to controlling shareholders over the last four quarters of KRW 18.3 billion is the starting point, but the Q4 2025 contribution of KRW 19.3 billion is large, so quarterly variation matters.

Net income attributable to controlling shareholders was KRW 10.9 billion in 2025 after the 2024 turn to profit, and losses in Q2 and Q3 2026 mean earnings continuity has not yet been confirmed.

The dividend rests on the cash dividend resolved alongside the fiscal 2025 financial statements in March 2026, and the dividend share of parent-only revenue moved from 0.93% in fiscal 2024 to 27.32% in Q1 2026.

Because affiliate dividends fund the holding company's dividends, the durability of payouts is tied to affiliate profit recovery. A discount to book value and falling profit exist at the same time, so how the market judges earnings durability shapes the interpretation.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-18

08

Bull factors

Operating turnaround and lower leverage

Operating profit of KRW 14.9 billion in 2025 marked a swing from operating loss, and the debt ratio fell from 410.1% in 2022 to 132.3% in 2025. Operating cash flow stayed positive, at KRW 17.3 billion in 2024 and KRW 26.9 billion in 2025. Of total equity of KRW 345.6 billion at end-2025, KRW 168.8 billion belonged to controlling shareholders.

Quarterly operating profit and revenue recovery in 2026

Operating profit was KRW 8.89 billion in Q1 2026 and KRW 7.24 billion in Q3 2026, both up year on year, and Q3 operating profit rose 18.1% year on year. Revenue increased in Q2 and Q3 2026, two consecutive quarters of growth, to KRW 157.8 billion in Q3. Q3 revenue was up 9.3% year on year.

Lower R&D spending and a changed cost base

Consolidated R&D expense fell from KRW 108 billion in 2023 to KRW 55.7 billion in 2024 and KRW 35.5 billion in 2025, a period in which operating results moved from loss to profit (FnGuide consolidated data).

Q1 2026 R&D expense of KRW 9.2 billion was up 14.6% year on year, so whether the cost reduction continues needs further confirmation. Because holding-company results depend on affiliate profits and dividends, affiliate profit improvement is a positive factor.

09

Bear factors

Lower net income attributable to controlling shareholders and renewed losses

Net income attributable to controlling shareholders was KRW 10.9 billion in 2025, down 82.7% year on year. Net loss attributable to controlling shareholders was KRW 16.4 million in Q2 2026 and KRW 2.36 billion in Q3 2026, two consecutive loss quarters.

The reason shareholder earnings turned negative in quarters with positive operating profit needs to be checked in the filings.

Thin operating margin and a smaller top line

Operating margin improved from -14.6% in 2022 to 2.5% in 2025 but remains thin. Revenue fell 10.1% year on year to KRW 590.9 billion in 2025, below the KRW 675.5 billion of 2022. Quarterly operating profit dropped 78.3% QoQ to KRW 1.93 billion in Q2 2026.

Debt scale and history of affiliate support

Total liabilities at end-2025 were KRW 457.3 billion, larger than total equity of KRW 345.6 billion. Guarantees for affiliates were reported at KRW 66.7 billion at end-2023, and affiliate losses have weighed on consolidated results. A Korean business news report said an affiliate and its subsidiary posted a KRW 21.5 billion loss in 2023.

10

Risk factors

Affiliate performance and R&D investment

Holding-company results depend on affiliate profit and dividends, and past affiliate losses have pulled down consolidated results. R&D expense fell from KRW 108 billion in 2023 to KRW 35.5 billion in 2025, so whether pipeline progress can continue is a point to monitor. Weaker affiliate results could also reduce the funds available for the holding company's dividends.

Debt and financing costs

Total liabilities at end-2025 were KRW 457.3 billion, and the debt ratio was 132.3%. Interest expense was KRW 30.1 billion in 2023, KRW 34.1 billion in 2024 and KRW 24.1 billion in 2025 (FnGuide consolidated data).

Financing costs are a driver of net income attributable to controlling shareholders, so interest expense and borrowing structure should be checked together.

Quarterly earnings volatility and one-off items

Net income attributable to controlling shareholders swung from KRW 19.3 billion in Q4 2025 to KRW 1.42 billion in Q1 2026 (down 92.6% QoQ) and then to a loss in Q2 2026. Quarterly swings are large, so a single quarter is not enough to read the trend. The effect of one-off items should be checked in the notes to the quarterly reports.

11

What to watch next

  1. By March 31, 2027

    Deadline for the 2026 annual business report. Annual operating margin, compared with 2.5% in 2025, and net income attributable to controlling shareholders are the annual checkpoints, along with how Q4 2026 results are reflected.

  2. March 2027 (expected timing of the regular general meeting)

    Based on the March 2026 precedent, when fiscal 2025 financial statements were approved and a cash dividend was resolved, the checkpoint is whether and how much dividend is resolved for fiscal 2026.

  3. By May 15, 2027

    Deadline for the Q1 2027 quarterly report. Year-on-year comparisons can be made against Q1 2026 operating profit of KRW 8.89 billion and net income attributable to controlling shareholders of KRW 1.42 billion.

  4. Mid-May 2027 (the Q1 2026 preliminary results were released on May 13, 2026)

    In the Q1 2027 preliminary results, the checkpoints are the pace of affiliate profit recovery and the level of R&D spending, which was KRW 9.2 billion in Q1 2026.

12

Overall view

Ildong Holdings is a holding company whose results depend on the profits and dividends of its affiliates. On reported figures, operating profit turned from loss to KRW 14.9 billion in 2025, and the debt ratio fell from 410.1% in 2022 to 132.3% in 2025.

Operating profit rose year on year in Q1 and Q3 2026, and revenue grew in Q2 and Q3 2026, two consecutive quarters. On the other side, net income attributable to controlling shareholders fell 82.7% to KRW 10.9 billion in 2025, and posted losses in Q2 and Q3 2026.

The last four quarters combined total KRW 18.3 billion of net income attributable to controlling shareholders, and the large Q4 2025 contribution of KRW 19.3 billion makes quarterly results uneven.

The share price sits at a discount to book value, but how that gap should be read depends on whether earnings continuity is confirmed.

Strengths include the operating turnaround, lower debt and lower R&D spending, while weaknesses include the swing to shareholder losses, affiliate guarantees and total liabilities of KRW 457.3 billion.

The next checkpoints are the 2026 annual business report due by March 31, 2027, the dividend resolution at the regular general meeting, and the Q1 2027 quarterly report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. kind.krx.co.kr
  2. kind.krx.co.kr
  3. kind.krx.co.kr
  4. kind.krx.co.kr
  5. kind.krx.co.kr
  6. kind.krx.co.kr
  7. pmstoryhub.com
  8. kind.krx.co.kr
  9. wiki.onul.works
  10. dealsite.co.kr
  11. saramin.co.kr
  12. medipana.com
  13. thepowernews.co.kr
  14. thebionews.net
  15. hankyung.com
  16. comp.fnguide.com
  17. pflow.keywordegg.com
  18. m.news.nate.com

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis